Moderna, Inc

Moderna, Inc

Moderna is an American biotechnology company focused on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

The US government recently signed a $ 1.5 billion agreement with the Moderna for Covid-19 vaccine. The Swiss government has also signed another agreement with the company.

Technically, the price has reached its trend line and a strong support level, and we can enter the position.

 

Summary of analysis and signal : 

Active

Entry point: 69

stop-loss: 62

Take profit 1: 83

Take profit 2: 94